Evaluation of the Role of Early Second Look TURBT in Management of High Risk Non Muscle Invasive Bladder Cancer
NCT07642102 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70
Last updated 2026-06-11
Summary
The aim is to evaluate the intraoperative, postoperative and pathologic findings of early second look TURBT and the factors affecting these findings to assess the value of early second TURBT in the management of high risk NMIBC.
Conditions
- Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive)
- Transurethral Resection of Bladder Tumor
Interventions
- PROCEDURE
-
early second look transurethral resection of bladder tumor
endoscopic early second look transurethral resection of bladder tumor after initial complete resection transurethral resection of non muscle invasive bladder tumor
Sponsors & Collaborators
-
Ain Shams University
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-05-02
- Primary Completion
- 2025-10-30
- Completion
- 2025-12-22
Countries
- Egypt
Study Locations
More Related Trials
-
Radical Cystectomy Versus Tri-Modal Therapy for Treatment of cT2N0M0 Urinary Bladder Transitional Cell Carcinoma
NCT07043790 ·Status: COMPLETED ·Phase: NA
-
Value of Immediate Post-operative Intravesical Epirubicin in Intermediate&High Risk Non Muscle Invasive Bladder Cancer
NCT02214602 ·Status: COMPLETED ·Phase: PHASE4
-
COMPARISON OF OBTURATOR NERVE BLOCK TECHNIQUES IN TURBT
NCT07481123 ·Status: COMPLETED ·Phase: NA
-
Can Second Resection for pT1 Bladder Cancer be Avoided After Initial En-Bloc Resection With Negative Safety Margins
NCT05969964 ·Status: RECRUITING
-
A Proposed Tetra-modal Treatment Protocol for Muscle Invasive Urothelial Carcinoma of the Urinary Bladder
NCT05503563 ·Status: UNKNOWN
-
Adjuvant Post-radical Cystectomy Treatment for Bladder Cancer
NCT01734798 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Post-voiding Reisdual Urine on Non-muscle Invasive Bladder Cancer Recurrence and Progression
NCT04617743 ·Status: COMPLETED
-
Impact of Time to Re-staging Transurethral Resection on Recurrence and Progression Rates
NCT04768894 ·Status: COMPLETED ·Phase: NA
-
The Necessity of a Second Transurethral Resection in High-risk Non-muscle-invasive Bladder Cancer Patients With Negative Urine Biomarker After Initial Transurethral Resection
NCT06287541 ·Status: RECRUITING ·Phase: NA
-
En-Bloc Resection of Bladder Tumors
NCT04784507 ·Status: UNKNOWN ·Phase: PHASE2
-
Holmium Laser En-Bloc Resection Versus Conventional Transurethral Resection of Bladder Tumors for Treatment of Non-muscle- Invasive Bladder Cancer
NCT07534631 ·Status: COMPLETED ·Phase: NA
-
A Phase 3 Study of UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
NCT04688931 ·Status: TERMINATED ·Phase: PHASE3
-
Intravesically Heated Thermo-chemotherapy With Mitomycin-C Prior to TURBT
NCT02471547 ·Status: UNKNOWN ·Phase: NA
-
Cryoablation Versus BCG Instillation Therapy for High-risk NMIBC
NCT06324058 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Hyperthermic Intravesical Perfusion for Muscle-invasive Bladder Urothelial Carcinoma
NCT05276167 ·Status: RECRUITING ·Phase: NA
-
Carboplatin-gemcitabine Versus Cisplatin- Gemcitabine as Neoadjuvant Chemotherapy for Treatment of Muscle Invasive Urinary Bladder Cancer
NCT05822934 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
AI-Guided TURBT for Bladder Cancer
NCT07727343 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Storz Professional Image Enhancement System Versus White Light Imaging Assisted TURBT for Treatment of NMIBC
NCT03138824 ·Status: UNKNOWN ·Phase: NA
-
Thulium Laser En-bloc Resection of Primary Non-muscle Invasive Bladder Cancer
NCT06818799 ·Status: COMPLETED ·Phase: NA
-
A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing
NCT07036731 ·Status: RECRUITING ·Phase: NA
-
Guiding Value of Urinary Tumor DNA Testing in Cystoscopy for High-Risk/Very High-Risk Non-Muscle-Invasive Bladder Cancer
NCT07180212 ·Status: RECRUITING ·Phase: NA
-
Trastuzumab Rezetecan and Adebrelimab as Neoadjuvant Therapy for HER2-Positive Muscle-Invasive Bladder Cancer
NCT07624201 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Optimal Adjuvant Intravesical Therapy for Intermediate Risk Non Muscle Invasive Bladder Cancer: A Randomized Controlled Trial
NCT05146635 ·Status: UNKNOWN ·Phase: NA
-
Predictive Value of E-cadherin, β-catenin and SOX4 in Recurrence and/or Progression of Non-muscle Invasive Urinary Bladder Transitional Cell Carcinoma. A Retrospective Study
NCT07657299 ·Status: COMPLETED
-
Holmium Versus Bipolar en Bloc Transurethral Resection of Urothelium Tumor of the Urinary Bladder
NCT04576286 ·Status: COMPLETED ·Phase: PHASE2